Non-Pharmacologic Therapies in PsO and PsA: 5 Things to Know
Psoriasis, which affects approximately 7.5 million people in the United States, is a chronic, immune-mediated dermatological disorder characterized by keratinocyte hyperproliferation, often presenting as erythematous, scaly plaques on the skin. In some cases, it is accompanied by psoriatic arthritis (PsA), a seronegative oligoarthritis marked by progressive joint pain and destruction. While pharmacologic interventions, including biologic … Read more